9.8.1: Drugs used in metabolic disorders

Part of chapter 9 Nutrition and Blood, section 9.8 Metabolic disorders

High-level prescribing trends for Drugs used in metabolic disorders (BNF section 9.8.1) across Hasp PCN - Hull Association of Similar Practices for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.

Chemicals

Betaine anhydrous (0908010T0)
Carglumic acid (0908010AD)
Cholesterol (0908010D0)
Cystine (0908010AI)
Glycerol phenylbutyrate (0908010AT)
Levocarnitine (0908010Z0)
Levocarnitine (0908010C0)
Mercaptamine (0908010E0)
Migalastat (0908010AQ)
Miglustat (0908010AC)
Nitisinone (0908010AF)
Sacrosidase (0908010Y0)
Sapropterin (0908010AU)
Sodium benzoate (0908010N0)
Sodium phenylbutyrate (0908010P0)
Sucrase (0908010AL)
Trientine dihydrochloride (0908010S0)
Zinc acetate (0908010AJ)
Feedback